QR kód

ENCOURAGING OUTCOMES OF SECOND ALLOGENEIC STEM CELL TRANSPLANT FOR ACUTE LEUKEMIAS AND MYELODYSPLASTIC SYNDROMES FROM TWO CENTERS IN SÃO PAULO, BRAZIL

Objectives: Second allogeneic Hematopoietic Stem Cell Transplant (HSCT) is the only curative treatment option for patients who relapse after a first transplant for malignant diseases. Previously reported outcomes for this intervention are often dismal, with high Relapse Incidence (RI), Non-Relapse M...

Celý popis

Uloženo v:
Hlavní autoři: EL Rosa, FS Azevedo, CC Justino, AM Fonseca, PHA Moraes, VC Molla, RS Szor, CD Liz, AG Guerra, MM Almeida, GMC Silva, CF Oliveira, TFN Araújo, LPDS Rocha, ML Puls, C Arrais
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier 2024-10-01
Edice:Hematology, Transfusion and Cell Therapy
On-line přístup:http://www.sciencedirect.com/science/article/pii/S2531137924021023
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky